Genomatix Filed Patent: Epigenetics in DNA Chip Analysis
The regulatory encyclopedia will be the result of over a decade of research and knowledge integration derived from comparative promoter sequence analysis, large scale literature data and text mining, expression profiling, phylogenetic analysis, and proteomics.
"This patent filing is completely in line with the Genomatix philosophy of a holistic approach towards systems biology, which needs to include all aspects of transcriptional regulation. We are confident that this approach will further improve understanding of biological processes and opens the door to a so far largely untapped field for pharmaceutical innovation. ", said Thomas Werner, CEO & CSO of Genomatix
Organizations
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.